Deudores Comerciales Cambio Fecha
AbbVie USD 12.77B 132M 2025-09
Agenus USD 22.44M 1.14M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Ardelyx USD 71.85M 4.76M 2025-12
aTyr Pharma USD 296.74M 295.7M 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Celldex Therapeutics USD 2.02M 1.92M 2025-12
Curis USD 2.55M 400K 2024-06
Eli Lilly USD 19.46B 2.25B 2025-09
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Incyte USD 1.02B 128.52M 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Prothena USD 5.16M 0 2023-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Xoma USD 14.78M 4.96M 2024-06